Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia

  • C. Owen Foothills Medical Centre
  • A. S. Gerrie University of British Columbia; BC Cancer
  • V. Banerji Cancer Care Manitoba
  • S. Assouline McGill University and Jewish General Hospital
  • C. Chen University of Toronto; Princess Margaret Cancer Centre
  • K. S. Robinson Dalhousie University; QEII Health Sciences Centre;
  • E. Lye Lymphoma Canada
  • G. Fraser McMaster University; Juravinski Cancer Centre
Keywords: Chronic lymphocytic leukemia, cll, treatment, prognosis, fitness

Abstract

Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.


Author Biographies

C. Owen, Foothills Medical Centre
Division of Hematology and Hematological Malignancies
A. S. Gerrie, University of British Columbia; BC Cancer
Division of Medical Oncology
V. Banerji, Cancer Care Manitoba
Department of Hematology and Medical Oncology
S. Assouline, McGill University and Jewish General Hospital
Department of Medical Oncology
C. Chen, University of Toronto; Princess Margaret Cancer Centre
Department of Medical Oncology
K. S. Robinson, Dalhousie University; QEII Health Sciences Centre;
Division of Hematology
G. Fraser, McMaster University; Juravinski Cancer Centre
Department of Oncology
Published
2018-11-02
How to Cite
Owen, C., Gerrie, A. S., Banerji, V., Assouline, S., Chen, C., Robinson, K. S., Lye, E., & Fraser, G. (2018). Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia. Current Oncology, 25(5). https://doi.org/10.3747/co.25.4092
Section
Practice Guideline